Key Takeaway
Acute illness-associated weakness was reported more often in the surveyed dystroglycanopathy group, especially in young children, but this mixed-gene retrospective evidence cannot define an individual emergency pathway or treatment.
Evidence Summary
Natural-history and survey study describing acute, transient weakness around febrile illness across several dystroglycanopathy genes.
Citation: Carlson CR, McGaughey SD, Eskuri JM, et al. Illness-associated muscle weakness in dystroglycanopathies. Neurology. 2017;89(23):2374-2380.
Key Takeaway
Acute illness-associated weakness was reported more often in the surveyed dystroglycanopathy group, especially in young children, but this mixed-gene retrospective evidence cannot define an individual emergency pathway or treatment.
Primary Sources
Primary indexed record for the paper summary on this page.
Publisher DOI landing page.
Full text used to check the mixed-gene population, survey design, record availability, funding, disclosures, and limitations.
Related Content
Paper Summary
Retrospective analysis relating self-reported middle-school activity to later motor and respiratory measures in 41 people with FKRP variants.
Paper Summary
Retrospective report of self-reported myoglobinuria and muscle pain in a 26-person FKRP-related LGMD2I cohort.
Glossary
A group of disorders caused by problems in alpha-dystroglycan glycosylation, including diseases linked to FKRP.